Table 3 Predictors of the liver disease in children with HIV infection (multiple regression analysis).

From: Prevalence and predictors of liver disease in HIV-infected children and adolescents

Predictor

Model for ALT

Model for AST

Model for bilirubin

Model for GGTP

Model for APRI

Model for FIB-4

β (SE)

p value

β (SE)

p value

β (SE)

p value

β (SE)

p value

β (SE)

p value

β (SE)

p value

Coinfection with HBV or HCV

73.15 (12.74)

<0.0001

39.00 (7.78)

<0.0001

88.35 (10.46)

<0.0001

0.64 (0.16)

0.0001

0.20 (0.06)

0.001

Duration of cART

−3,34 (1.44)

0.02

Age

3.51 (1.29)

0.008

−0.34 (0.12)

0.008

0.01 (0.004)

0.006

Hemoglobin

2.46 (0.47)

<0.0001

4.46 (2.19)

0.04

Total cholesterol

0.22 (0.06)

0.0007

Platelets

−0.002 (0.0006)

0.01

−0.001 (0.0003)

<0.0001

HIV viral load (detectable)

58.91 (14.15)

0.0001

41.62 (8.86)

<0.0001

5.47 (2.22)

0.01

0.75 (0.17)

0.0001

0.21 (0.06)

0.002

BMI z-score

−1.29 (0.59)

0.03

Model performance

R2

0.47

0.40

0.33

0.55

0.40

0.61

Adjusted R2

0.44

0.38

0.29

0.53

0.38

0.59

  1. Six separate multivariate models were constructed for the following markers of the liver disease: ALT, AST, bilirubin, GGTP, APRI, and FIB-4. Candidate predictors (age, sex, BMI z-score, CD4 count, duration of cART, haemoglobin level, platelet count, total cholesterol, HBV or HCV coinfection, viral load, and AIDS history) were entered into the model, regardless of the results of the univariate analysis. After entering all variables into the model, the variables that showed least significant associations were subsequently excluded until all variables remained significant (p < 0.05). Only predictors showing significance were presented. β – coefficient, SE – standard error. ALT – alanine aminotransferase, AST – aspartate aminotransferase, APRI – aspartate transferase to platelet ratio index, cART – combination antiretroviral therapy, FIB-4 – Fibrosis-4 index, GGTP – gamma glutamyl transferase, HBV – hepatitis B virus, HCV – hepatitis C virus.